| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Country's Decision or any other Communication
Record information and status
Record ID
115094
Status
Published
Date of creation
2019-08-07 22:40 UTC (tim.strabala@epa.govt.nz)
Date of publication
2019-08-07 22:40 UTC (tim.strabala@epa.govt.nz)

General information
Country submitting the decision or communication
  • New Zealand
Competent National Authority(ies) responsible for the decision or communication
Environmental Protection Authority
215 Lambton Quay
Private Bag 63002
Wellington
New Zealand
Phone:+64 (0)4 474 5591
Fax:+64 (0)4 914 0433
Email:neworganisms@epa.govt.nz
Url:New Organisms, Environmental Protection Authority
Title / Reference number of the decision or communication
APP202371 Decision
Date of the decision
2019-04-16
Is the decision taken prior to entry into force of the Protocol?
No
Is this an amendment to a previous decision / communication?
No
Decision or communication details
Subject(s) of the decision
  • Decision on LMOs for intentional introduction into the environment (according Article 10 or domestic regulatory framework)
Was the decision triggered by a request for a transboundary movement of LMOs into the country?
No
Does the decision apply to transboundary movements of LMO(s) into the country?
Yes
Importer’s or Applicant’s contact details
Mr Alan Carter
General Manager
Sanofi New Zealand
PO Box 12851 Penrose
Auckland
New Zealand
Phone:+64 9 5801810
Fax:+64 9 5801811
Email:alan.carter@sanofi.com
Url:Sanofi Australia New Zealand
Result of the decision
  • Approval of the import/use of the LMO(s) without conditions
Does the decision involve field trials?
No
Does the decision involve commercial release?
Yes
LMO identification
Imojev (Japanese Encephalitis Chimeric Virus Vaccine; JE-CV)
Risk assessment
EPA staff assessment report on application APP202371 - To import and release a genetically modified live-attenuated vaccine (IMOJEV®) to protect humans against Japanese encephalitis.
Imojev (Japanese Encephalitis Chimeric Virus Vaccine; JE-CV)
Decision document
Decision document